Jennifer M. S. Sucre
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jennifer M. S. Sucre has a total of 533 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan A. Kropski
Vanderbilt University Medical Center Department of Medicine Nashville, TN
20 shared publications - Nicholas M. Negretti
Vanderbilt University Medical Center
17 shared publications Christopher S. Jetter
Department of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, Nashville, TN, USA
16 shared publications- Erin J. Plosa
Division of Neonatology, Department of Pediatrics, Vanderbilt University Medical Center, 2200 Children’s Way, 11111 DOT, Nashville, TN, 37232, USA
9 shared publications John T. Benjamin
School of Medicine, Stanford University
9 shared publications- Susan H. Guttentag
Department of Pediatrics
9 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
IL-8 in Human Glioblastoma Tumors Instructs Immunosuppressive Myeloid Cells
Adult glioblastoma (GBM) is an aggressive brain tumor that has yet to benefit from advances in immunotherapy. Prior studies report contrasting leukocyte immunophenotypes between tumors and an association between myeloid macrophage infiltration and worse patient outcomes. IL-8, a cytokine with both inflammatory and suppressive roles, was recently associated with M2 macrophage phenotypes in GBM. These observations raise key questions: do GBM macrophages suppress or support other immune cells, is IL-8 in GBM a mechanistic driver of GBM macrophage function, and can IL-8 instruct macrophages in situ within tumors? Here, functional experiments with primary human GBM tumor cells from initial surgical resections showed that IL-8 from GBM contributes to and is sufficient to instruct monocyte-derived macrophages that suppress healthy T cells. Notably, IL-8 protein expression was enriched in aggressive tumors contacting the V-SVZ region and was not associated with increased infiltration of cells expressing the IL-8 receptors CXCR1/CXCR2. Suppressor cells instructed by GBM ex vivo phenotypically matched myeloid macrophages observed in vivo, and neutralizing IL-8 during instruction blocked this and restored T cell proliferation. Analysis of IL-8 RNA showed the cytokine is primarily produced by CD45- tumor cells. These results suggest a model where ongoing IL-8 production by GBM cells maintains an immunosuppressive microenvironment by signaling to myeloid macrophages within the tumor. Immunotherapies relying on T cells should now investigate whether IL-8 blockade prevents instruction of macrophages into tumor-protective suppressor cells.
- 12 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
Open AccessIL-8 in Human Glioblastoma Tumors Instructs Immunosuppressive Myeloid Cells
Adult glioblastoma (GBM) is an aggressive brain tumor that has yet to benefit from advances in immunotherapy. Prior studies report contrasting leukocyte immunophenotypes between tumors and an association between myeloid macrophage infiltration and worse patient outcomes. IL-8, a cytokine with both inflammatory and suppressive roles, was recently associated with M2 macrophage phenotypes in GBM. These observations raise key questions: do GBM macrophages suppress or support other immune cells, is IL-8 in GBM a mechanistic driver of GBM macrophage function, and can IL-8 instruct macrophages in situ within tumors? Here, functional experiments with primary human GBM tumor cells from initial surgical resections showed that IL-8 from GBM contributes to and is sufficient to instruct monocyte-derived macrophages that suppress healthy T cells. Notably, IL-8 protein expression was enriched in aggressive tumors contacting the V-SVZ region and was not associated with increased infiltration of cells expressing the IL-8 receptors CXCR1/CXCR2. Suppressor cells instructed by GBM ex vivo phenotypically matched myeloid macrophages observed in vivo, and neutralizing IL-8 during instruction blocked this and restored T cell proliferation. Analysis of IL-8 RNA showed the cytokine is primarily produced by CD45- tumor cells. These results suggest a model where ongoing IL-8 production by GBM cells maintains an immunosuppressive microenvironment by signaling to myeloid macrophages within the tumor. Immunotherapies relying on T cells should now investigate whether IL-8 blockade prevents instruction of macrophages into tumor-protective suppressor cells.
- Open Access
- 27 October 2026
- Published by Wolters Kluwer Health in Circulation Research
Natural Killer Cell TGF-β Signaling Regulates Postnatal Lung Development
BACKGROUND: Bronchopulmonary dysplasia (BPD) is a disease of neonatal lung development that is linked to impaired pulmonary vascularization, dysregulated TGF-β (transforming growth factor-β) signaling, and the accumulation of senescent cells. Despite the established role of TGF-β signaling in promoting vascular remodeling and suppressing the senolytic activity of natural killer (NK) cells, the contribution of NK cell TGF-β signaling to postnatal lung patterning and the pathogenesis of BPD remains unclear. METHODS: Mice bearing an NK cell-selective deletion of the type-II TGF-β receptor ( Tgfbr2 NK− /− ) were analyzed for vascular and alveolar structure, lung NK cell infiltration, senescence markers, and lung function testing across neonatal and adult time points. Lung tissue from both neonatal mice and human infants with BPD was assessed by single-cell RNA sequencing. The effects of enhanced NK cell activity in a hyperoxia-induced model of BPD were examined in Tgfbr2 NK−/− neonates, as well as pharmacologically, using the TGF-β ligand trap/IL-15 superagonist, HCW9218. RESULTS: Neonatal Tgfbr2 NK−/− mice exhibited a baseline reduction in distal arteriolar density, impaired alveolarization, and sex-specific deficits in long-term lung function. Single-cell RNA sequencing identified excessive clearance of senescent endothelial cells by TGF-β-insensitive NK cells in the lungs of Tgfbr2 NK−/− neonates. This enhanced NK cell activity promoted a BPD-like phenotype in naïve Tgfbr2 NK−/− mice but protected these animals from impaired lung development under hyperoxia. Sequencing of lung tissue from human infants with BPD confirmed excessive TGF-β signaling and cytotoxic impairment in NK cells. Treatment with HCW9218 prevented senescent cell accumulation and rescued lung development in the hyperoxia mouse model. CONCLUSIONS: TGF-β is a tunable regulator of NK cell senolytic activity that is essential for normal postnatal lung development. Excessive NK cell TGF-β signaling contributes to impaired lung development with neonatal hyperoxia and may serve as a viable therapeutic target in human BPD.
- 27 October 2026
- Published by Wolters Kluwer Health in Circulation Research
Open AccessNatural Killer Cell TGF-β Signaling Regulates Postnatal Lung Development
BACKGROUND: Bronchopulmonary dysplasia (BPD) is a disease of neonatal lung development that is linked to impaired pulmonary vascularization, dysregulated TGF-β (transforming growth factor-β) signaling, and the accumulation of senescent cells. Despite the established role of TGF-β signaling in promoting vascular remodeling and suppressing the senolytic activity of natural killer (NK) cells, the contribution of NK cell TGF-β signaling to postnatal lung patterning and the pathogenesis of BPD remains unclear. METHODS: Mice bearing an NK cell-selective deletion of the type-II TGF-β receptor ( Tgfbr2 NK− /− ) were analyzed for vascular and alveolar structure, lung NK cell infiltration, senescence markers, and lung function testing across neonatal and adult time points. Lung tissue from both neonatal mice and human infants with BPD was assessed by single-cell RNA sequencing. The effects of enhanced NK cell activity in a hyperoxia-induced model of BPD were examined in Tgfbr2 NK−/− neonates, as well as pharmacologically, using the TGF-β ligand trap/IL-15 superagonist, HCW9218. RESULTS: Neonatal Tgfbr2 NK−/− mice exhibited a baseline reduction in distal arteriolar density, impaired alveolarization, and sex-specific deficits in long-term lung function. Single-cell RNA sequencing identified excessive clearance of senescent endothelial cells by TGF-β-insensitive NK cells in the lungs of Tgfbr2 NK−/− neonates. This enhanced NK cell activity promoted a BPD-like phenotype in naïve Tgfbr2 NK−/− mice but protected these animals from impaired lung development under hyperoxia. Sequencing of lung tissue from human infants with BPD confirmed excessive TGF-β signaling and cytotoxic impairment in NK cells. Treatment with HCW9218 prevented senescent cell accumulation and rescued lung development in the hyperoxia mouse model. CONCLUSIONS: TGF-β is a tunable regulator of NK cell senolytic activity that is essential for normal postnatal lung development. Excessive NK cell TGF-β signaling contributes to impaired lung development with neonatal hyperoxia and may serve as a viable therapeutic target in human BPD.
- Open Access
- 26 October 2026
- Published by Springer Nature in Journal of Perinatology
- p. 1-6
Temporal trends and clinical factors associated with ketamine infusion in hospitalized infants with bronchopulmonary dysplasia
Objective: To characterize temporal trends in ketamine infusion use in extremely preterm infants with severe bronchopulmonary dysplasia (sBPD) and identify associated clinical factors. Study design: We conducted a 15-year (2010–2024) retrospective cohort study of extremely preterm infants with sBPD. Time was analyzed as a categorical variable in three 5-year epochs. Ketamine exposures were described, and multivariable logistic regression estimated associations between time periods and use, adjusting for clinical characteristics. Results: Among 8888 infants with sBPD, 112 (1.3%) received ketamine infusion, with use increasing over time and rising most sharply between 2020 and 2024. Pulmonary hypertension (adjusted odds ratio, aOR 5.47, 95% CI 1.65–18.09), stage II/III necrotizing enterocolitis (aOR 2.06, 1.24–3.43), and tracheostomy (aOR 8.32, 3.50–19.77) were independently associated with use. Conclusions: Ketamine infusions in sBPD are uncommon but have increased over time, particularly since 2020. Use is associated with markers of greater illness severity.
- 26 October 2026
- Published by Springer Nature in Journal of Perinatology
- p. 1-6
Open AccessTemporal trends and clinical factors associated with ketamine infusion in hospitalized infants with bronchopulmonary dysplasia
Objective: To characterize temporal trends in ketamine infusion use in extremely preterm infants with severe bronchopulmonary dysplasia (sBPD) and identify associated clinical factors. Study design: We conducted a 15-year (2010–2024) retrospective cohort study of extremely preterm infants with sBPD. Time was analyzed as a categorical variable in three 5-year epochs. Ketamine exposures were described, and multivariable logistic regression estimated associations between time periods and use, adjusting for clinical characteristics. Results: Among 8888 infants with sBPD, 112 (1.3%) received ketamine infusion, with use increasing over time and rising most sharply between 2020 and 2024. Pulmonary hypertension (adjusted odds ratio, aOR 5.47, 95% CI 1.65–18.09), stage II/III necrotizing enterocolitis (aOR 2.06, 1.24–3.43), and tracheostomy (aOR 8.32, 3.50–19.77) were independently associated with use. Conclusions: Ketamine infusions in sBPD are uncommon but have increased over time, particularly since 2020. Use is associated with markers of greater illness severity.
- Open Access
Integrin α3β1 is required for alveolar-capillary barrier formation through regulation of epithelial differentiation
Laminin-binding integrins regulate critical morphogenic processes, but their specific roles in lung development are unknown. In this study, we evaluated a novel in vivo model of epithelial α3 subunit deletion in the murine lung with a multiomics approach to investigate the role of the epithelial α3β1 integrin during murine lung development. We demonstrate that α3β1 integrin is dispensable for airway branching morphogenesis. Instead, in vivo deletion of α3β1 integrin impaired alveolar epithelial cell differentiation and disrupted alveolar-capillary barrier formation, functionally limiting gas exchange. A discontinuous alveolar BM contained abnormal collagen IV and laminin networks and widened the gap between epithelial and endothelial cells in the alveolar-capillary barrier niche. Mechanistically, mice deficient in epithelial α3β1 integrin possessed an intracellular trafficking and secretion defect for basement membrane components. Thus, integrin α3β1 orchestrates the temporal maturation of alveolar epithelial cells required for organization of the alveolar-capillary barrier. Summary statement: Integrin α3β1 is required for alveolar-capillary barrier formation through regulation of alveolar epithelial differentiation and alveolar BM composition.
Open AccessIntegrin α3β1 is required for alveolar-capillary barrier formation through regulation of epithelial differentiation
Laminin-binding integrins regulate critical morphogenic processes, but their specific roles in lung development are unknown. In this study, we evaluated a novel in vivo model of epithelial α3 subunit deletion in the murine lung with a multiomics approach to investigate the role of the epithelial α3β1 integrin during murine lung development. We demonstrate that α3β1 integrin is dispensable for airway branching morphogenesis. Instead, in vivo deletion of α3β1 integrin impaired alveolar epithelial cell differentiation and disrupted alveolar-capillary barrier formation, functionally limiting gas exchange. A discontinuous alveolar BM contained abnormal collagen IV and laminin networks and widened the gap between epithelial and endothelial cells in the alveolar-capillary barrier niche. Mechanistically, mice deficient in epithelial α3β1 integrin possessed an intracellular trafficking and secretion defect for basement membrane components. Thus, integrin α3β1 orchestrates the temporal maturation of alveolar epithelial cells required for organization of the alveolar-capillary barrier. Summary statement: Integrin α3β1 is required for alveolar-capillary barrier formation through regulation of alveolar epithelial differentiation and alveolar BM composition.
- Open Access
Lymphangiogenesis is Critical for Healing and Survival in a Murine Model of Laryngotracheal Injury
Objective: Lymphatic dysfunction has been implicated in exacerbating fibrosis in numerous diseases, yet the role of the lymphatic system in laryngotracheal injury has not previously been explored. This study aims to evaluate lymphatic vascular remodeling in a murine model of laryngotracheal stenosis (LTS) and determine how pharmacologic blockade of lymphangiogenesis impacts airway healing after mucosal injury. Methods: LTS was induced in C57BL6 mice using an established chemomechanical injury model. Lymphatic density was quantified using LYVE-1 immunohistochemistry. Mice were treated with the VEGFR-3-selective tyrosine kinase inhibitor SAR131675 to block lymphangiogenesis after injury. Outcomes assessed included survival, histopathology, immunohistochemistry, and Evans blue dye vascular leakage. Results: Laryngotracheal injury induced a substaantial increase in subepithelial lymphatic vessel density concomitant with fibrotic remodeling. Pharmacologic inhibition of VEGFR-3 signaling with SAR131675 abrogated this lymphangiogenic response and resulted in markedly increased mortality, impaired epithelial repair with obstructive sloughing, increased edema, and persistent histopathologic evidence of tissue injury. A qualitative increase in pathologic fibrocellular remodeling was also observed, though with no measurable difference in lamina propria thickness. Conclusion: These findings establish lymphatic remodeling as an essential component of successful airway repair following mucosal injury. Lymphatic dysfunction is a common feature of known risk factors for LTS including diabetes, obesity, and prematurity, and can be exacerbated by positive pressure ventilation. Disruption of the lymphangiogenic response to airway injury may lead to stasis of pro-inflammatory factors that result in chronic inflammation, maladaptive remodeling, and pathologic tissue changes. The lymphatic vasculature is a viable target for future mechanistic study and potential therapeutic intervention following airway injury.
Open AccessLymphangiogenesis is Critical for Healing and Survival in a Murine Model of Laryngotracheal Injury
Objective: Lymphatic dysfunction has been implicated in exacerbating fibrosis in numerous diseases, yet the role of the lymphatic system in laryngotracheal injury has not previously been explored. This study aims to evaluate lymphatic vascular remodeling in a murine model of laryngotracheal stenosis (LTS) and determine how pharmacologic blockade of lymphangiogenesis impacts airway healing after mucosal injury. Methods: LTS was induced in C57BL6 mice using an established chemomechanical injury model. Lymphatic density was quantified using LYVE-1 immunohistochemistry. Mice were treated with the VEGFR-3-selective tyrosine kinase inhibitor SAR131675 to block lymphangiogenesis after injury. Outcomes assessed included survival, histopathology, immunohistochemistry, and Evans blue dye vascular leakage. Results: Laryngotracheal injury induced a substaantial increase in subepithelial lymphatic vessel density concomitant with fibrotic remodeling. Pharmacologic inhibition of VEGFR-3 signaling with SAR131675 abrogated this lymphangiogenic response and resulted in markedly increased mortality, impaired epithelial repair with obstructive sloughing, increased edema, and persistent histopathologic evidence of tissue injury. A qualitative increase in pathologic fibrocellular remodeling was also observed, though with no measurable difference in lamina propria thickness. Conclusion: These findings establish lymphatic remodeling as an essential component of successful airway repair following mucosal injury. Lymphatic dysfunction is a common feature of known risk factors for LTS including diabetes, obesity, and prematurity, and can be exacerbated by positive pressure ventilation. Disruption of the lymphangiogenic response to airway injury may lead to stasis of pro-inflammatory factors that result in chronic inflammation, maladaptive remodeling, and pathologic tissue changes. The lymphatic vasculature is a viable target for future mechanistic study and potential therapeutic intervention following airway injury.
- Open Access
- 1 July 2026
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 9 (7) , e2622790
Neonatal Outcomes Following Selective Serotonin Reuptake Inhibitor Use During Pregnancy.
Evaluating the safety of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is challenging due to ethical barriers to randomized trials and potential confounding in observational studies. To compare neonatal outcomes for pregnancies with SSRI continuation vs those with SSRI discontinuation using a target trial framework. This cohort study comprised target trials using electronic health records of linked mothers and neonates from a single academic center. The periconception trial examined congenital anomalies with first-trimester exposure, and the early-pregnancy trial evaluated nonanomaly outcomes with first- or second-trimester exposure. Participants were women with singleton pregnancies (2006 to 2022) with SSRI use within the 2 years before conception and at least 1 prenatal visit during the first trimester (periconception trial) or during the first or second trimester (early-pregnancy trial). Data were analyzed from May 2022 to December 2023. SSRI continuation vs discontinuation during pregnancy. Apgar scores, meconium in amniotic fluid, neonatal intensive care unit (NICU) admission, preterm birth, birth weight, respiratory distress, feeding problems, hypoglycemia, hypothermia, pulmonary hypertension, cesarean delivery, and congenital anomalies. The early-pregnancy trial included 1014 pregnancies (mean [SD] maternal age, 30.3 [5.4] years). The periconception trial included 807 pregnancies (mean [SD] maternal age, 30.4 [5.5] years). SSRI continuation was associated with lower Apgar scores at 1 minute (mean difference [MD], -0.39; 95% CI, -0.60 to -0.18) and 5 minutes (MD, -0.28; 95% CI, -0.42 to -0.13), and increased risk of meconium in amniotic fluid (odds ratio [OR], 1.73; 95% CI, 1.22 to 2.45). No significant associations were found for congenital anomalies (OR, 1.09; 95% CI, 0.63 to 1.90), though this result should be interpreted with caution given limited sample size. No differences were found for neonatal intensive care unit admission (OR, 1.23; 95% CI, 0.82 to 1.83) or other outcomes. In this cohort study, SSRI continuation during pregnancy was associated with impaired neonatal adaptation but not with severe complications or NICU admission. These findings highlight the importance of appropriate comparator selection to minimize confounding and illustrate how target trial emulation can improve causal inference in studies of medication safety during pregnancy.
- 1 July 2026
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 9 (7) , e2622790
Open AccessNeonatal Outcomes Following Selective Serotonin Reuptake Inhibitor Use During Pregnancy.
Evaluating the safety of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is challenging due to ethical barriers to randomized trials and potential confounding in observational studies. To compare neonatal outcomes for pregnancies with SSRI continuation vs those with SSRI discontinuation using a target trial framework. This cohort study comprised target trials using electronic health records of linked mothers and neonates from a single academic center. The periconception trial examined congenital anomalies with first-trimester exposure, and the early-pregnancy trial evaluated nonanomaly outcomes with first- or second-trimester exposure. Participants were women with singleton pregnancies (2006 to 2022) with SSRI use within the 2 years before conception and at least 1 prenatal visit during the first trimester (periconception trial) or during the first or second trimester (early-pregnancy trial). Data were analyzed from May 2022 to December 2023. SSRI continuation vs discontinuation during pregnancy. Apgar scores, meconium in amniotic fluid, neonatal intensive care unit (NICU) admission, preterm birth, birth weight, respiratory distress, feeding problems, hypoglycemia, hypothermia, pulmonary hypertension, cesarean delivery, and congenital anomalies. The early-pregnancy trial included 1014 pregnancies (mean [SD] maternal age, 30.3 [5.4] years). The periconception trial included 807 pregnancies (mean [SD] maternal age, 30.4 [5.5] years). SSRI continuation was associated with lower Apgar scores at 1 minute (mean difference [MD], -0.39; 95% CI, -0.60 to -0.18) and 5 minutes (MD, -0.28; 95% CI, -0.42 to -0.13), and increased risk of meconium in amniotic fluid (odds ratio [OR], 1.73; 95% CI, 1.22 to 2.45). No significant associations were found for congenital anomalies (OR, 1.09; 95% CI, 0.63 to 1.90), though this result should be interpreted with caution given limited sample size. No differences were found for neonatal intensive care unit admission (OR, 1.23; 95% CI, 0.82 to 1.83) or other outcomes. In this cohort study, SSRI continuation during pregnancy was associated with impaired neonatal adaptation but not with severe complications or NICU admission. These findings highlight the importance of appropriate comparator selection to minimize confounding and illustrate how target trial emulation can improve causal inference in studies of medication safety during pregnancy.
- Open Access
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 330 (6) , L755-L766
AlveolEye: rapid and precise lung morphometry guided by computer vision
Calculating lung morphometric measurements is time-intensive, with a high degree of interrater variability. We developed a semiautomated tool, AlveolEye, which uses computer vision to perform rapid and precise lung morphometry, reducing variability and improving efficiency. AlveolEye presents an opportunity for improved rigor, efficiency, and reproducibility in studies of lung development, injury, and regeneration.
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 330 (6) , L755-L766
Open AccessAlveolEye: rapid and precise lung morphometry guided by computer vision
Calculating lung morphometric measurements is time-intensive, with a high degree of interrater variability. We developed a semiautomated tool, AlveolEye, which uses computer vision to perform rapid and precise lung morphometry, reducing variability and improving efficiency. AlveolEye presents an opportunity for improved rigor, efficiency, and reproducibility in studies of lung development, injury, and regeneration.
- Open Access
- 12 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
FOXF2 regulates pericyte–endothelial signaling required for vascular homeostasis after neonatal hyperoxic lung injury
Pulmonary vascular development is essential for alveolarization, and disruption of this process contributes to pathogenesis of bronchopulmonary dysplasia (BPD). Proper vascular development requires an orchestration of many cell types within the lung. However, the transcriptional mechanisms by which pericytes support the endothelium in the postnatal lung remain poorly understood. Herein, we identify FOXF2 as a critical transcription factor that governs pericyte maturation and function during postnatal lung development and regeneration. FOXF2 expression in pericytes increases postnatally and is selectively downregulated after neonatal hyperoxic injury. Pdgfrb-CreER mediated Foxf2 deletion in pericytes leads to pericyte hyperplasia, impaired migration, and reduced expression of angiogenic factors such as ANGPTL4. Transcriptomic and genomic studies demonstrate that FOXF2 maintains chromatin accessibility at pro-angiogenic loci and modulates paracrine signaling essential for endothelial regeneration. Loss of FOXF2 disrupts pericyte–endothelial crosstalk, leading to impaired angiogenesis and alveolarization as well as increased vascular permeability after neonatal lung injury. Altogether, FOXF2 acts as a key transcriptional regulator of the pericyte-driven vascular niche in the neonatal lung, highlighting the pathogenic role of pericyte dysfunction in BPD.
- 12 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessFOXF2 regulates pericyte–endothelial signaling required for vascular homeostasis after neonatal hyperoxic lung injury
Pulmonary vascular development is essential for alveolarization, and disruption of this process contributes to pathogenesis of bronchopulmonary dysplasia (BPD). Proper vascular development requires an orchestration of many cell types within the lung. However, the transcriptional mechanisms by which pericytes support the endothelium in the postnatal lung remain poorly understood. Herein, we identify FOXF2 as a critical transcription factor that governs pericyte maturation and function during postnatal lung development and regeneration. FOXF2 expression in pericytes increases postnatally and is selectively downregulated after neonatal hyperoxic injury. Pdgfrb-CreER mediated Foxf2 deletion in pericytes leads to pericyte hyperplasia, impaired migration, and reduced expression of angiogenic factors such as ANGPTL4. Transcriptomic and genomic studies demonstrate that FOXF2 maintains chromatin accessibility at pro-angiogenic loci and modulates paracrine signaling essential for endothelial regeneration. Loss of FOXF2 disrupts pericyte–endothelial crosstalk, leading to impaired angiogenesis and alveolarization as well as increased vascular permeability after neonatal lung injury. Altogether, FOXF2 acts as a key transcriptional regulator of the pericyte-driven vascular niche in the neonatal lung, highlighting the pathogenic role of pericyte dysfunction in BPD.
- Open Access
- 27 January 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (5)
BRD4 promotes endodermal cell fate during mammalian lung development
Lung development relies on diverse cell intrinsic and extrinsic mechanisms to ensure proper cellular differentiation and compartmentalization. In addition, it requires precise integration of multiple signaling pathways to temporally regulate morphogenesis and appropriate cell specification. To accomplish this, organogenesis relies on epigenetic and transcriptional regulators to promote cell fate and inhibit alternative cell fates. Using genetic mouse and human embryonic stem cell (hESC) differentiation models, tissue explants, and single-cell transcriptomic analysis, we demonstrated that Bromodomain Containing Protein 4 (BRD4) is required for mammalian lung morphogenesis and cell fate. Endodermal deletion of BRD4 impaired epithelial-mesenchymal crosstalk, leading to disrupted proximal-distal patterning and branching morphogenesis. Moreover, temporal deletion of BRD4 revealed developmental stage–specific defects in airway and alveolar epithelial cell specification with a predominant role in proximal airway cell fate. Similarly, BRD4 promoted lung endodermal cell differentiation into airway lineages in a hESC-derived lung organoid model. Together, these data demonstrate that BRD4 orchestrates early lung morphogenesis and separately regulates cell specification, indicating a multifunctional and evolutionarily conserved role for BRD4 in mammalian lung development.
- 27 January 2026
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (5)
Open AccessBRD4 promotes endodermal cell fate during mammalian lung development
Lung development relies on diverse cell intrinsic and extrinsic mechanisms to ensure proper cellular differentiation and compartmentalization. In addition, it requires precise integration of multiple signaling pathways to temporally regulate morphogenesis and appropriate cell specification. To accomplish this, organogenesis relies on epigenetic and transcriptional regulators to promote cell fate and inhibit alternative cell fates. Using genetic mouse and human embryonic stem cell (hESC) differentiation models, tissue explants, and single-cell transcriptomic analysis, we demonstrated that Bromodomain Containing Protein 4 (BRD4) is required for mammalian lung morphogenesis and cell fate. Endodermal deletion of BRD4 impaired epithelial-mesenchymal crosstalk, leading to disrupted proximal-distal patterning and branching morphogenesis. Moreover, temporal deletion of BRD4 revealed developmental stage–specific defects in airway and alveolar epithelial cell specification with a predominant role in proximal airway cell fate. Similarly, BRD4 promoted lung endodermal cell differentiation into airway lineages in a hESC-derived lung organoid model. Together, these data demonstrate that BRD4 orchestrates early lung morphogenesis and separately regulates cell specification, indicating a multifunctional and evolutionarily conserved role for BRD4 in mammalian lung development.
- Open Access
Fishing with Two Lines: A Hybrid Approach to Spatial Transcriptomic Discovery
Spatial transcriptomics faces a trade-off between the number of genes assayed and depth of per-gene sensitivity. We developed a 'dual chemistry' method that combines the high sensitivity of a 10X Genomics Xenium V1 custom panel (up to 480 genes) with the broad coverage of the Prime 5K panel (5001 genes) on a single tissue section. This involved co-hybridizing Prime and V1 probes and sequentially running the V1 and Prime decoding chemistries. Applied to a human lung tissue microarray, we observed high concordance between the V1 and Prime chemistries when run independently (on serial sections) and the dual chemistry runs. Overlapping genes (profiled on both V1 and Prime chemistries) showed similar expression patterns in the dual run demonstrating the fidelity of the assay. By combining information from both the V1 and Prime chemistries within the same cell, we retain more cells, gain valuable additional information, and enable both high sensitivity profiling and discovery.
Open AccessFishing with Two Lines: A Hybrid Approach to Spatial Transcriptomic Discovery
Spatial transcriptomics faces a trade-off between the number of genes assayed and depth of per-gene sensitivity. We developed a 'dual chemistry' method that combines the high sensitivity of a 10X Genomics Xenium V1 custom panel (up to 480 genes) with the broad coverage of the Prime 5K panel (5001 genes) on a single tissue section. This involved co-hybridizing Prime and V1 probes and sequentially running the V1 and Prime decoding chemistries. Applied to a human lung tissue microarray, we observed high concordance between the V1 and Prime chemistries when run independently (on serial sections) and the dual chemistry runs. Overlapping genes (profiled on both V1 and Prime chemistries) showed similar expression patterns in the dual run demonstrating the fidelity of the assay. By combining information from both the V1 and Prime chemistries within the same cell, we retain more cells, gain valuable additional information, and enable both high sensitivity profiling and discovery.